Pages that link to "Q33874621"
Jump to navigation
Jump to search
The following pages link to Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes (Q33874621):
Displaying 50 items.
- Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives (Q26781613) (← links)
- Of mice and women: a comparative tissue biology perspective of breast stem cells and differentiation (Q26796835) (← links)
- Clinical implications of the intrinsic molecular subtypes of breast cancer (Q26800996) (← links)
- World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research (Q26827259) (← links)
- Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition (Q26851765) (← links)
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development (Q27009424) (← links)
- Molecular Classification of Triple-Negative Breast Cancer (Q28076661) (← links)
- Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer (Q30275521) (← links)
- Identifying gene regulatory network rewiring using latent differential graphical models. (Q30276421) (← links)
- Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy (Q33441772) (← links)
- Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies (Q33591876) (← links)
- Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers (Q33646271) (← links)
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease (Q33769821) (← links)
- Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer (Q33812500) (← links)
- Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry (Q33859719) (← links)
- Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy (Q33866887) (← links)
- Novel therapeutic strategies in the treatment of triple-negative breast cancer (Q33887682) (← links)
- Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer. (Q33892756) (← links)
- Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants (Q33915057) (← links)
- Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype? (Q34476337) (← links)
- Computational identification of multi-omic correlates of anticancer therapeutic response (Q34567814) (← links)
- Subtyping of triple-negative breast cancer: implications for therapy (Q34734477) (← links)
- Standard of care and promising new agents for triple negative metastatic breast cancer (Q34774884) (← links)
- Pharmacological profiling of kinase dependency in cell lines across triple-negative breast cancer subtypes (Q34978420) (← links)
- β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells. (Q35137658) (← links)
- Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth (Q35145319) (← links)
- Molecular characterization and targeted therapeutic approaches in breast cancer (Q35530143) (← links)
- Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6 (Q35625440) (← links)
- Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family (Q35816817) (← links)
- Advances in small-molecule drug discovery for triple-negative breast cancer. (Q35818491) (← links)
- CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis (Q35832374) (← links)
- Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells (Q35849077) (← links)
- Autophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathway. (Q35853834) (← links)
- Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage (Q35855936) (← links)
- Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. . (Q35911470) (← links)
- Derivation of a fifteen gene prognostic panel for six cancers. (Q35953479) (← links)
- Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine (Q35993199) (← links)
- Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro (Q36027858) (← links)
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. (Q36054418) (← links)
- Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging (Q36109265) (← links)
- Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances (Q36157045) (← links)
- Clinical implications of molecular heterogeneity in triple negative breast cancer. (Q36271396) (← links)
- Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue. (Q36334470) (← links)
- Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer. (Q36413493) (← links)
- Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage (Q36413546) (← links)
- Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapse (Q36524110) (← links)
- Sense-antisense gene-pairs in breast cancer and associated pathological pathways (Q36561721) (← links)
- [(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer (Q36568348) (← links)
- IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors (Q36664343) (← links)
- γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers (Q36771883) (← links)